P038 AN OPEN-LABEL TRIAL OF INFLIXIMAB FOR INDUCING AND MAINTAINING CLINICAL AND ENDOSCOPIC REMISSION IN PATIENTS WITH ACUTE, SEVERE ULCERATIVE COLITIS | Zendy

AI Assistant Blog Pricing

P038 AN OPEN-LABEL TRIAL OF INFLIXIMAB FOR INDUCING AND MAINTAINING CLINICAL AND ENDOSCOPIC REMISSION IN PATIENTS WITH ACUTE, SEVERE ULCERATIVE COLITIS

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.